David Gaist

Medicine & Life Sciences

1. Denmark 100%
2. Cerebral Hemorrhage 96%
3. Case-Control Studies 80%
4. Stroke 79%
5. Confidence Intervals 61%
6. Twins 59%
7. Hydroxymethylglutaryl-CoA Reductase Inhibitors 48%
8. Odds Ratio 45%
9. Registries 44%
10. Population 37%
11. Subarachnoid Hemorrhage 37%
12. Polyneuropathies 35%
13. Aspirin 31%
14. Migraine Disorders 31%
15. Migraine with Aura 28%
16. Aged, 80 and over 28%
17. Pharmaceutical Preparations 25%
18. Anticoagulants 25%
19. Subdural Hematoma 25%
20. Glioma 23%
21. Incidence 22%
22. Myasthenia Gravis 21%
23. Cohort Studies 20%
24. Transient Ischemic Attack 20%
25. Hydrochlorothiazide 19%
26. Health 19%
27. Neural Conduction 18%
28. Oxaliplatin 17%
29. Platelet Aggregation Inhibitors 16%
30. Peripheral Nerves 16%
31. Skin Neoplasms 16%
32. General Practice 16%
33. Hand Strength 15%
34. Prescriptions 15%
35. Headache 15%
36. Elderly 15%
37. Mortality 14%
38. Nerve Fibers 14%
39. Twin Studies 13%
40. Drug Utilization 13%
41. Azathioprine 13%
42. Population Control 12%
43. International Normalized Ratio 12%
44. Warfarin 12%
45. Serotonin Uptake Inhibitors 12%
46. Logistic Models 12%
47. Skin 12%
48. Hormone Replacement Therapy 11%
49. Dizygotic Twins 11%
50. Epilepsy 11%